Penumbra, Inc. (PEN)
330.02
+1.06
(+0.32%)
USD |
NYSE |
Apr 02, 15:28
Penumbra Research and Development Expense (TTM) : 83.18M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Revvity, Inc. | 215.84M |
| Globus Medical, Inc. | 146.94M |
| Abbott Laboratories | 2.89B |